Dr Chen was previously the president and CEO of Tanox, a publicly held biopharmaceutical company which was acquired by Genentech in 2007. Dr Chen holds a PhD from Baylor College of Medicine in Houston, Texas as well as an MBA from Arthur D Little School of Management in Boston, Massachusetts.
James Cooper, the chairman of the board of Theranostics, said: “We strongly believe that Danong’s impressive scientific and business credentials combined with her proven management and leadership skills will enable Theranostics Health to achieve its true potential in the years ahead.”